- Home
- CINT vs VSTM Comparison
CINT vs VSTM Comparison
Compare CINT & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CINT
- VSTM
- Stock Information
- Founded
- CINT 1995
- VSTM 2010
- Country
- CINT Brazil
- VSTM United States
- Employees
- CINT N/A
- VSTM N/A
- Industry
- CINT EDP Services
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- CINT Technology
- VSTM Health Care
- Exchange
- CINT Nasdaq
- VSTM Nasdaq
- Market Cap
- CINT 605.6M
- VSTM 581.6M
- IPO Year
- CINT 2021
- VSTM 2012
- Fundamental
- Price
- CINT $4.21
- VSTM $9.25
- Analyst Decision
- CINT Strong Buy
- VSTM Strong Buy
- Analyst Count
- CINT 5
- VSTM 9
- Target Price
- CINT $6.96
- VSTM $13.38
- AVG Volume (30 Days)
- CINT 167.9K
- VSTM 2.6M
- Earning Date
- CINT 11-12-2025
- VSTM 11-04-2025
- Dividend Yield
- CINT N/A
- VSTM N/A
- EPS Growth
- CINT 46.10
- VSTM N/A
- EPS
- CINT 0.27
- VSTM N/A
- Revenue
- CINT $467,906,000.00
- VSTM $13,379,000.00
- Revenue This Year
- CINT $12.57
- VSTM $88.60
- Revenue Next Year
- CINT $12.91
- VSTM $416.99
- P/E Ratio
- CINT $15.51
- VSTM N/A
- Revenue Growth
- CINT 1.90
- VSTM 33.79
- 52 Week Low
- CINT $3.98
- VSTM $3.46
- 52 Week High
- CINT $8.00
- VSTM $11.25
- Technical
- Relative Strength Index (RSI)
- CINT 34.15
- VSTM 56.31
- Support Level
- CINT $4.45
- VSTM $7.29
- Resistance Level
- CINT $4.87
- VSTM $8.86
- Average True Range (ATR)
- CINT 0.21
- VSTM 0.69
- MACD
- CINT -0.02
- VSTM 0.01
- Stochastic Oscillator
- CINT 1.32
- VSTM 71.25
About CINT CI&T Inc
CI&T Inc is engaged in providing plans, design, and software engineering services to enable digital transformation for companies. The company mainly develops customizable software through the implementation of several software solutions, including Machine Learning, Artificial Intelligence (AI), Analytics, Cloud, and Mobility technologies. The majority of the revenue is generated from the North America and Europe, followed by Asia, Pacific and Japan.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.